Related Experiment Video
Updated: Sep 17, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Knowledge-based immune-therapeutic advances for transplantation and cancer
1Emeritus Professor of Transplantation Biology, Division of Immunology & Inflammation, Department of Medicine, Imperial College, London, United Kingdom.
Understanding immune responses to foreign entities has advanced immunotherapy, improving transplantation survival. Further research into tumor antigens and immune evasion is crucial for optimizing cancer treatments.
Area of Science:
- Immunology
- Transplantation Science
- Cancer Immunotherapy
Background:
- Immune responses to 'foreign' or 'non-self' entities are highly complex.
- Significant advancements in transplantation have reduced acute rejection and improved long-term survival.
- Current tumor immunotherapy faces challenges due to tumor evasion and the need for optimized antigen identification.
Purpose of the Study:
- To review the progress and complexities in understanding immune responses.
- To highlight the potential of this knowledge in optimizing immunotherapy, particularly in transplantation and cancer.
- To identify future research directions and explore new paradigms.
Main Methods:
- Review of basic and translational research from the late 1960s to present.
- Analysis of strategies combining chemotherapy, immunosuppressive agents, and surgical techniques in transplantation.
- Examination of tumor antigen identification and immune evasion mechanisms in cancer immunotherapy.
Main Results:
- Remarkable progress in transplantation leading to reduced rejection and increased long-term survival.
- Identification of numerous tumor antigens recognized by B and T cell receptors.
- Recognition of the complexity of immune responses and the need for further optimization in immunotherapy.
Conclusions:
- Increased knowledge of immune responses offers a more hopeful outlook for optimizing immunotherapy.
- Continued basic and translational research is essential for further breakthroughs.
- Exploring new paradigms is necessary to overcome challenges in transplantation and cancer immunotherapy.
Related Concept Videos
Tumor Immunotherapy
Cell-mediated Immune Responses
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

